Total Payments
$2,033
2024 Payments
$141.85
Companies
18
Transactions
110
Medicare Patients
3,052
Medicare Billing
$191,000
Payment Breakdown by Category
Food & Beverage$2,033 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,033 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $399.78 | 33 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $265.71 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $216.19 | 16 | $0 (2020) |
| Dexcom, Inc. | $177.28 | 3 | $0 (2024) |
| Amgen Inc. | $150.67 | 9 | $0 (2020) |
| Intuitive Surgical, Inc. | $123.86 | 2 | $0 (2019) |
| Medtronic MiniMed, Inc. | $122.31 | 6 | $0 (2020) |
| Gilead Sciences, Inc. | $102.77 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101.32 | 7 | $0 (2019) |
| Tandem Diabetes Care, Inc. | $95.05 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.85 | 2 | Dexcom, Inc. ($85.35) |
| 2021 | $77.00 | 1 | DEXCOM, INC. ($77.00) |
| 2020 | $271.94 | 17 | Novo Nordisk Inc ($62.20) |
| 2019 | $709.91 | 37 | Novo Nordisk Inc ($164.25) |
| 2018 | $616.53 | 46 | Novo Nordisk Inc ($162.83) |
| 2017 | $215.98 | 7 | SANOFI-AVENTIS U.S. LLC ($146.87) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $85.35 | General |
| Category: Endocrinology | ||||||
| 06/12/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $56.50 | General |
| Category: Endocrinology | ||||||
| 12/16/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $77.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2020 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Durable Pump | ||||||
| 10/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 09/29/2020 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| Category: Insulin Pump | ||||||
| 07/16/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 05/12/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Cardiovascular | ||||||
| 04/22/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular | ||||||
| 03/05/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Diabetes | ||||||
| 03/04/2020 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Durable Pump | ||||||
| 02/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiology | ||||||
| 02/21/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Respiratory | ||||||
| 02/19/2020 | Tandem Diabetes Care, Inc. | t:slim X2 insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: Endocrinology | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2020 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Diabetes | ||||||
| 01/14/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory and Allergy | ||||||
| 01/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Diabetes | ||||||
| 12/04/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Diabetes | ||||||
| 12/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: DIABETES | ||||||
| 11/14/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Durable Pump | ||||||
| 11/06/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Obesity | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 918 | 2,942 | $192,605 | $60,230 |
| 2022 | 26 | 1,229 | 3,546 | $254,855 | $80,134 |
| 2021 | 24 | 905 | 1,972 | $149,380 | $50,637 |
Total Patients
3,052
Total Services
8,460
Medicare Billing
$191,000
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 1,440 | $50,338 | $25,929 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 187 | $77,231 | $15,106 | 19.6% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 45 | 89 | $15,842 | $3,463 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $12,222 | $2,545 | 20.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 97 | 147 | $6,615 | $2,408 | 36.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 155 | 306 | $2,958 | $2,403 | 81.2% |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 2023 | 12 | 154 | $7,854 | $1,555 | 19.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 117 | $3,042 | $1,097 | 36.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 71 | 99 | $2,871 | $1,025 | 35.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 19 | 23 | $2,553 | $930.35 | 36.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 47 | 84 | $2,016 | $742.56 | 36.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 48 | 56 | $2,016 | $734.72 | 36.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 22 | 23 | $1,840 | $667.23 | 36.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 18 | 24 | $1,104 | $398.40 | 36.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 37 | 43 | $989.00 | $350.17 | 35.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 24 | $1,248 | $201.78 | 16.2% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 11 | 14 | $532.00 | $194.60 | 36.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 28 | 30 | $480.00 | $169.80 | 35.4% |
| 82310 | Calcium level, total | Office | 2023 | 21 | 31 | $434.00 | $156.86 | 36.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 28 | 30 | $420.00 | $152.40 | 36.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 1,740 | $55,851 | $29,597 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 272 | $112,608 | $25,136 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $23,584 | $5,575 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 24 | $13,872 | $2,912 | 21.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 104 | 157 | $7,065 | $2,596 | 36.7% |
About Dr. Jennifer Poste, MD
Dr. Jennifer Poste, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598036295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Poste, MD has received a total of $2,033 in payments from pharmaceutical and medical device companies, with $141.85 received in 2024. These payments were reported across 110 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,033).
As a Medicare-enrolled provider, Poste has provided services to 3,052 Medicare beneficiaries, totaling 8,460 services with total Medicare billing of $191,000. Data is available for 3 years (2021–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Vancouver, WA
- Active Since 01/26/2012
- Last Updated 04/28/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1598036295
Products in Payments
- Ozempic (Drug) $259.16
- FARXIGA (Drug) $191.76
- SOLIQUA (Drug) $181.56
- Repatha (Biological) $131.93
- Da Vinci Surgical System (Device) $123.86
- JARDIANCE (Drug) $121.88
- Tresiba (Drug) $105.73
- Minimed 670G System (Device) $100.52
- Dexcom G6 Transmitter (Medical Supply) $85.35
- DEXCOM G6 TRANSMITTER (Device) $77.00
- TOUJEO (Drug) $72.63
- Vascepa (Drug) $66.49
- t:slim X2 Insulin Pump with Control-IQ (Device) $56.50
- XARELTO (Drug) $55.60
- TRULICITY (Drug) $31.79
- Omnipod (Device) $23.20
- t:slim X2 insulin pump (Device) $21.96
- Guardian Connect (Device) $21.79
- Victoza (Drug) $19.50
- EVENITY (Biological) $18.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Vancouver
Dr. Katherine Chubinskaya, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $18,130
Endocrinology, Diabetes & Metabolism $18,130
Dr. Stacey Condren, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $6,381
Endocrinology, Diabetes & Metabolism $6,381
Saumya Kumar, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,826
Endocrinology, Diabetes & Metabolism $5,826
Christina Orr, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $2,878
Endocrinology, Diabetes & Metabolism $2,878
Michael Decker, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,417
Endocrinology, Diabetes & Metabolism $1,417
Dr. Leslie Colip, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $665.79
Endocrinology, Diabetes & Metabolism $665.79